InvestorsHub Logo
Followers 3
Posts 389
Boards Moderated 0
Alias Born 02/23/2016

Re: None

Thursday, 01/19/2017 7:01:11 AM

Thursday, January 19, 2017 7:01:11 AM

Post# of 3545
Pulmatrix Receives Patents Important to its Inhaled Drug Delivery Technology

LEXINGTON, Mass., Dec. 19, 2016 /PRNewswire/ -- Pulmatrix, Inc. (PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it has received five patents over the last 12 months

http://finance.yahoo.com/news/pulmatrix-receives-patents-important-inhaled-145000650.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PULM News